The trajectory of companies tied to the drug's legacy presents a challenging investment picture . While the initial success generated substantial gains, generic alternatives have significantly impacted https://monobookmarks.com/story21522818/copyright-s-flagship-product-and-pharma-a-uncertain-opportunity